FMO2 ameliorates nonalcoholic fatty liver disease by suppressing ER-to-Golgi transport of SREBP1.

已完结 10 由 123 发布于 2024/5/4 17:37:52

DOI:10.1097/HEP.0000000000000643
作者：Changle Ke, Changchen Xiao, Jiamin Li, Xianpeng Wu, Yu Zhang, Yongjian Chen, Shuyuan Sheng, Zaiyang Fu, Lingjun Wang, Cheng Ni, Jing Zhao, Yanna Shi, Yan Wu, Zhiwei Zhong, Jinliang Nan, Wei Zhu, Jinghai Chen, Rongrong Wu, Xinyang Hu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1097/HEP.0000000000000643
备注：希望图片清晰一些

Wolters Kluwer Ovid

Abstract：Background and aims: NAFLD comprises a spectrum of liver disorders with the initial abnormal accumulation of lipids in hepatocytes called NAFL, progressing to the more serious NASH in a subs

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerHigh temperature ceramic thermal insulation material